Rare diseases
Investigational molecules
Locations
Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
GermanyA Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment
GermanyStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
GermanyA study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia
GermanyA Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
GermanyA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
GermanyStudy of nedosiran for patients with primary hyperoxaluria type 1 and severe kidney impairment with or without dialysis
GermanyStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
GermanyA study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes
GermanyStudy comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
